Lipoprotein(a) levels in chronic renal disease states, dialysis and transplantation

Wiley - Tập 22 Số 3 - Trang 243-248 - 1992
Ashley Irish1, Leon A. Simons, Elliott Savdie, James M. Hayes, Judith Simons
1Lipid Research Department, St Vincent's Hospital, Sydney, NSW, Australia.

Tóm tắt

Abstract:Lipoprotein(a) is an independent risk factor for cardiovascular disease. Lipoprotein(a) levels were measured in 196 patients (103 Male [M]: 93 Female [F]) with chronic renal diseases and in 116 controls. Median levels of Lipoprotein(a) [Lp(a)] were found to be significantly elevated in patients with untreated chronic renal disease (285, 285 mg/L; M, F; range 30–1675 mg/L) and in those treated with continuous ambulatory peritoneal dialysis (320, 603; M, F; range 50–1450) compared with controls (70, 51; M, F; range 1–750; p<0.01 Males, p<0.001 Females). Lp(a) levels in patients treated by haemodialysis (133, 35; M, F; range 5–685) and renal transplantation (100, 95; MJF; range 10–1700) were not significantly different from controls. Lipoprotein(a) levels correlated inversely with serum albumin in the combined dialysis group (r= ‐034, p < 0.001), and with urinary protein loss in the combined transplant and chronic renal diseases groups (r = 0.29, p <0.01). This correlation of Lp(a) with protein metabolism suggests a similarity with changes in other apolipoprotein‐B containing lipoproteins in nephrosis. These findings may be relevant to the increased risk of atherosclerosis in patients with chronic renal disease and to their optimum mode of renal replacement therapy. (Aust NZ J Med 1992; 22:243–248.)

Từ khóa


Tài liệu tham khảo

10.1126/science.2530631

10.1161/01.CIR.74.4.758

10.1001/jama.1986.03380180102027

10.1016/0021-9150(86)90048-1

10.1016/0033-0620(83)90027-0

Ibels LS., 1975, Studies on the nature and causes of hyperlipidemia uraemia, dialysis and transplantation, Q J Med, 176, 601

10.1038/ki.1981.62

10.7326/0003-4819-92-5-634

Parra J., 1987, Lp(a) Lipoprotein in patients with chronic renal failure treated by haemodialysis, Clin Chem, 33, 721, 10.1093/clinchem/33.5.721

Karadi I., 1989, Lp(a) lipoprotein concentration in serum of patients with heavy proteinuria of different origin, Clin Chem., 35, 2121, 10.1093/clinchem/35.10.2121

Takegoshi T., 1990, A study of clinical significance of Lp(a) lipoprotein in patients with chronic renal failure treated by haemodialysis, Nippon-Jinzo-Gakkai-Shi, 32, 667

10.2169/internalmedicine1962.30.21

10.1038/330132a0

10.1097/00041433-199010000-00002

Rees A., 1990, The ape(a) gene: Structure/function relationships and the possible link with thrombotic atheromatous disease, Br Med Bull, 46, 873, 10.1093/oxfordjournals.bmb.a072444

10.1016/S0167-7306(08)60198-2

10.1016/0021-9150(90)90177-K

10.1016/0021-9150(86)90099-7

10.1038/ki.1987.151

10.1016/0026-0495(90)90074-M

Kaysen GA, 1991, Hyperlipidemia of the nephrotic syndrome, Kidney Int, 39, S8

10.1038/ki.1984.167

10.1038/ki.1990.73

Black IW, 1991, Effect of renal transplantation on lipoprotein a prospective study (Abst), Aust NZ J Med, 21, 2

10.1056/NEJM199005243222104

10.1038/ki.1988.129

10.1007/BF00858827

Thông tin
Thông tin xuất bản

Wiley

Tập 22 Số 3

243-248

Thông tin tác giả